
MindMaze
Founded Year
2012Stage
Acq - Pending | AliveTotal Raised
$348.53MValuation
$0000Mosaic Score The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.
-114 points in the past 30 days
About MindMaze
MindMaze provides digital neurotherapeutics services and focuses on the healthcare sector with an emphasis on brain health and recovery. The company offers a suite of medical-grade software, tailored interactive content, and proprietary peripherals designed to restore motor, cognitive, and cardiovascular functions following neural injuries, degeneration, and aging. It was founded in 2012 and is based in Lausanne, Switzerland.
Loading...
ESPs containing MindMaze
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The virtual physical therapy platforms market focuses on delivering physical therapy services to patients through remote digital channels. This market includes a range of providers, such as telehealth platforms, online therapy services, and virtual reality rehabilitation systems. The solutions offered by these providers include personalized exercise therapy, behavioral health support, pain educati…
MindMaze named as Challenger among 14 other companies, including Omada Health, Hinge Health, and Sword.
Loading...
Research containing MindMaze
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned MindMaze in 2 CB Insights research briefs, most recently on Jun 23, 2023.
Expert Collections containing MindMaze
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MindMaze is included in 5 Expert Collections, including AR/VR.
AR/VR
1,509 items
This collection includes companies creating hardware and/or software for augmented reality, virtual reality, and mixed reality applications.
Unicorns- Billion Dollar Startups
1,277 items
Gaming
5,683 items
Gaming companies are defined as those developing technologies for the PC, console, mobile, and/or AR/VR video gaming market.
Digital Health
11,408 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Telehealth
3,122 items
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
MindMaze Patents
MindMaze has filed 54 patents.
The 3 most popular patent topics include:
- neurophysiology
- sensors
- classification algorithms

Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
8/24/2020 | 8/6/2024 | Virtual reality, Neurophysiology, Neuroscience, Neurotechnology, Electroencephalography | Grant |
Application Date | 8/24/2020 |
---|---|
Grant Date | 8/6/2024 |
Title | |
Related Topics | Virtual reality, Neurophysiology, Neuroscience, Neurotechnology, Electroencephalography |
Status | Grant |
Latest MindMaze News
Jun 20, 2025
The Business Research Company's Latest Report Explores Market Driver, Trends, Regional Insights - Market Sizing & Forecasts Through 2034” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, June 20, 2025 / EINPresswire.com / -- Prominently, the neuroplasticity market size has seen significant exponential growth in recent years. In particular, the market size will rise from $5.34 billion in 2024 to $6.59 billion in 2025, echoing a compound annual growth rate CAGR of 23.4%. This growth during the historic period is attributable to the rising interest in brain-computer interface technologies, rising funding for neuroscience research, a surge in mental health concerns globally, increasing clinical validation of neuroplasticity-based therapies, and a growing use of digital therapeutics in cognitive care. What Can Be The Future Growth Prospects For The Neuroplasticity Market? It is predicted that the neuroplasticity market size will continue to experience robust growth over the next few years. As forecasts indicate, the market size will reach a staggering $15.18 billion in 2029, maintaining a CAGR of 23.2%. This growth can be attributed to numerous factors including increasing integration of AI in neurotechnology, growing demand for personalized neurotherapies, surging application of virtual reality in neurorehabilitation, escalation in the usage of wearable brain-monitoring devices, and a proliferation of investments in cognitive enhancement startups. Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=24334&type=smp What Factors Could Drive This Predicted Growth In The Neuroplasticity Market? Neurological disorders are anticipated to be a major growth driver for the neuroplasticity market. These disorders, which affect the brain, spinal cord, and nerves, lead to a range of physical, cognitive, and behavioural impairments. The escalating prevalence of diseases such as Alzheimer's, Parkinson's, epilepsy, and multiple sclerosis due to aging populations and lifestyle factors is driving global growth in neurological disorders. An aging global population is primarily responsible for this increase, as longer life expectancy raises the risk of developing age-related neurological conditions, resulting in higher incidence rates worldwide. Due to these factors, neuroplasticity is leveraging the growing prevalence of neurological disorders to foster the demand for advanced therapies and rehabilitation technologies. For instance, in October 2023, according to the World Federation of Neurology, a UK-based association of national neurological societies, more than 40% of the global population currently experiences some form of neurological condition. This figure is expected to nearly double by 2050. Who Are The Impacting Players In The Neuroplasticity Market? The key industry players operating in the Neuroplasticity market are Abbott Laboratories, Medtronic PLC, Otsuka Pharmaceutical, Boston Scientific Corporation, Biogen Inc., Neurocrine Biosciences, Axsome Therapeutics, NeuroPace Inc., BrainsWay Ltd., Magstim, MindMaze, Emotiv Inc., BrainCo, ElectroCore, NeuroMetrix, Sage Therapeutics, Soterix Medical, Neurable, NeuroSigma Inc., Cognixion, NeuroTracker. These entities play a crucial role in shaping the market with the development of innovative technologies and solutions. Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/neuroplasticity-global-market-report What Are The Recent Advancements By These Key Players In The Market? Becoming a central part of the conversation, many businesses operating in the neuroplasticity market are focusing on developing advanced technologies. Notably, brain-computer interfaces and neural implants establish direct communication pathways between the brain and external devices. BCIs typically enable control of computers or prosthetics through brain signals, while neural implants are devices that actively monitor, stimulate, or modulate neural activity for therapeutic or functional enhancement. How Is The Neuroplasticity Market Segmented? 1 By Product Type: Software-Based Solutions, Hardware-Based Solutions 2 By Technology Type: Artificial Intelligence, Virtual Reality, Neurostimulation, Wearable Technology 3 By Application: Stroke Rehabilitation, Traumatic Brain Injury TBI Rehabilitation, Neurodegenerative Disorders, Learning And Memory Enhancement, Mental Health Disorders 4 By End User: Hospitals And Clinics, Research Institutes And Academic Centers, Pharmaceutical And Biotechnology Companies, Other End Users Subsegment: 1 By Software-Based Solutions: Cognitive Training Programs, Neurofeedback Software, Brain Simulation Platforms, Mobile Neurotherapy Apps, Virtual Reality Rehabilitation Software, AI-Based Cognitive Assessment Tools 2 By Hardware-Based Solutions: EEG Headsets, Transcranial Magnetic Stimulation TMS Devices, Transcranial Direct Current Stimulation tDCS Devices, Brain-Computer Interface BCI Systems, Wearable Neurostimulation Devices, Neuroimaging And Monitoring Equipment What Are The Regional Insights Into The Neuroplasticity Market? In 2024, North America dominated the neuroplasticity market. It is expected that Asia-Pacific will be the quickest growing region in the coming years. The neuroplasticity market report covers a wide range of geographical locations – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Browse Through More Similar Reports By The Business Research Company: Intraoperative Neuromonitoring Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/intraoperative-neuromonitoring-global-market-report Neurodegenerative Disorder Therapeutics Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report Neuroendocrine Tumor Treatment Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/neuroendocrine-tumor-treatment-global-market-report About The Business Research Company Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game. Contact us at: The Business Research Company: https://www.thebusinessresearchcompany.com/ Americas +1 3156230293 Asia +44 2071930708 Europe +44 2071930708 Email us at info@tbrc.info Follow us on: LinkedIn: https://in.linkedin.com/company/the-business-research-company YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model Oliver Guirdham The Business Research Company info@tbrc.info Visit us on social media: LinkedIn Facebook X Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
MindMaze Frequently Asked Questions (FAQ)
When was MindMaze founded?
MindMaze was founded in 2012.
Where is MindMaze's headquarters?
MindMaze's headquarters is located at Chemin de Roseneck 5, Lausanne.
What is MindMaze's latest funding round?
MindMaze's latest funding round is Acq - Pending.
How much did MindMaze raise?
MindMaze raised a total of $348.53M.
Who are the investors of MindMaze?
Investors of MindMaze include Genesis Growth Tech Acquisition, AlbaCore Capital, Salica Investments, Concord Health Partners, Leonardo DiCaprio and 5 more.
Who are MindMaze's competitors?
Competitors of MindMaze include Brainomix and 6 more.
Loading...
Compare MindMaze to Competitors

XRHealth focuses on providing therapeutic care through the use of technology in the healthcare domain. The company offers a range of services, including virtual reality therapy for physical and mental health conditions, occupational therapy, and online physical therapy. It is primarily aimed at patients seeking treatment for conditions such as chronic pain, stress and anxiety, and neurological disorders. It was formerly known as VRHealth. The company was founded in 2016 and is based in Needham, Massachusetts.
VoithAI is involved in healthcare technology with a focus on artificial intelligence. It provides digital tools that analyze medical data and streamline workflows. Its tools are used within the healthcare sector for various purposes. It was founded in 2025 and is based in London, United Kingdom.

Ziehm Imaging develops and distributes mobile x-ray based imaging solutions within the healthcare sector. The company specializes in mobile C-arms that provide intraoperative imaging with features including 3D imaging capabilities and dose reduction technology. Ziehm Imaging offers imaging solutions for the medical community, including applications in cardiovascular interventions and other clinical areas. It was founded in 1972 and is based in Orlando, Florida.

Tyromotion focuses on technology-based therapeutic devices in the rehabilitation and therapy sector. The company provides products aimed at assisting patients with motor impairments, using robotics, sensor systems, virtual reality, and gamification to aid recovery. Tyromotion's devices work with the TyroS software, which combines clinical expertise and therapeutic programs. It was founded in 2007 and is based in Graz, Austria.
ifeel provides online therapy services within the mental health sector. It allows individuals facing various life challenges, such as stress, anxiety, and depression, to connect with therapists through digital platforms. It was founded in 2017 and is based in Madrid, Spain.

Lyra Health operates in workforce mental health care within the health benefits industry. The company provides a digital platform that connects employees to mental health providers and tools, utilizing artificial intelligence (AI) for provider matching and offering evidence-based support. Lyra Health serves employers seeking to provide mental health benefits and support employee well-being. It was founded in 2015 and is based in Burlingame, California.
Loading...